HER-2 evaluation in a specific gastric cancer population with the highest rate of mortality in Spain

Journal of Oncology

Volumn , Issue , 2011, Pages

  Cidon, E U ^a   Centeno, R G ^a   Lagarto, E G ^a   Peral, J I ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STOMACH CANCER;

EID: 84855290961     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/391564     Document Type: Article

References (25)

1. Layke J. C., Lopez P. P., Gastric cancer: diagnosis and treatment options American Family Physician 2004 69 5 1133 1145
2. Archie V., Kauh J., Jones D. V., Cruz V., Karpeh M. S., Thomas C. R., Gastric cancer: standards for the 21st century Critical Reviews in Oncology/Hematology 2006 57 2 123 131 (Pubitemid 43140743)
3. Van Cutsem E., Van de Velde C., Roth A., Lordick F., Khne C. H., Cascinu S., Aapro M., Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)gastrointestinal cancer group European Journal of Cancer 2008 44 2 182 194
4. Shibata A., Parsonnet J., Schottenfeld D., Fraumeni J. F. Jr., Stomach cancer Cancer Epidemiology and Prevention 2006 3rd Oxford, UK Oxford University Press 707 720
5. Hamashima C., Shibuya D., Yamazaki H., Inoue K., Fukao A., Saito H., Sobue T., The Japanese guidelines for gastric cancer screening Japanese Journal of Clinical Oncology 2008 38 4 259 267 (Pubitemid 351583989)
6. Cncer en cifras: cncer gstrico. Asociacin Espaola Contra el Cncer (AECC), 2002
7. Cervantes A., Georgoulias V., Falcone A., State of the art treatment for gastric cancer: future directions European Journal of Cancer, Supplement 2004 2 7 40 47 (Pubitemid 38726107)
8. Grvalos C., Jimeno A., HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target Annals of Oncology 2008 19 9 1523 1529
9. Scartozzi M., Galizia E., Freddari F., Berardi R., Cellerino R., Cascinu S., Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches Cancer Treatment Reviews 2004 30 5 451 459 (Pubitemid 38968125)
10. Guy P. M., Platko J. V., Cantley L. C., Cerione R. A., Carraway K. L., Insect cell-expressed p180(erbB3) possesses an impaired tyrosine kinase activity Proceedings of the National Academy of Sciences of the United States of America 1994 91 17 8132 8136
11. Tapia C., Glatz K., Novotny H., Lugli A., Horcic M., Seemayer C. A., Tornillo L., Terracciano L., Spichtin H., Mirlacher M., Simon R., Sauter G., Close association between HER-2 amplification and overexpression in human tumors of non-breast origin Modern Pathology 2007 20 2 192 198 (Pubitemid 46422173)
12. Takehana T., Kunitomo K., Kono K., Kitahara F., Iizuka H., Matsumoto Y., Fujino M. A., Ooi A., Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay International Journal of Cancer 2002 98 6 833 837 (Pubitemid 34286677)
13. Tateishi M., Toda T., Minamisono Y., Nagasaki S., Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma Journal of Surgical Oncology 1992 49 4 209 212
14. Sasano H., Date F., Imatani A., Asaki S., Nagura H., Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells Human Pathology 1993 24 6 584 589 (Pubitemid 23162224)
15. Yonemura Y., Ninomiya I., Yamaguchi A., Fushida S., Kimura H., Ohoyama S., Miyazaki I., Endou Y., Tanaka M., Sasaki T., Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer Cancer Research 1991 51 3 1034 1038
16. Ishida T., Tsujisaki M., Hanzawa Y., Hirakawa T., Hinoda Y., Imai K., Yachi A., Significance of erbB-2 gene product as a target molecule for cancer therapy Scandinavian Journal of Immunology 1994 39 5 459 466 (Pubitemid 24227769)
17. Tokunaga A., Onda M., Okuda T., Teramoto T., Fujita I., Mizutani T., Kiyama T., Yoshiyuki T., Nishi K., Matsukura N., Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer Cancer 1995 75 6 1418 1425
18. Funato T., Kozawa K., Fujimaki S., Miura T., Kaku M., Increased sensitivity to cisplatin in gastric cancer by antisense inhibition of the HER-2/neu (c-erbB-2) gene Chemotherapy 2001 47 4 297 303 (Pubitemid 32588790)
19. Garca I., Vizoso F., Martn A., Sanz L., Abdel-Lah O., Raigoso P., Garca-Muiz J. L., Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer Annals of Surgical Oncology 2003 10 3 234 241 (Pubitemid 40486955)
20. Uchino S., Tsuda H., Maruyama K., Kinoshita T., Sasako M., Saito T., Kobayashi M., Hirohashi S., Overexpression of c-erbB-2 protein in gastric cancer: its correlation with long-term survival of patients Cancer 1993 72 11 3179 3184 (Pubitemid 23356757)
21. Tanner M., Hollmén M., Junttila T. T., Kapanen A. I., Tommola S., Soini Y., Helin H., Salo J., Joensuu H., Sihvo E., Elenius K., Isola J., Amplification of HER-2 in gastric carcinoma: association with topoisomerase II gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab Annals of Oncology 2005 16 2 273 278 (Pubitemid 40309309)
22. Bang Y. J., Van Cutsem E., Feyereislova A., Chung H. C., Shen L., Sawaki A., Lordick F., Ohtsu A., Omuro Y., Satoh T., Aprile G., Kulikov E., Hill J., Lehle M., Rschoff J., Kang Y. K., Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial The Lancet 2010 376 9742 687 697
23. Yano T., Ochiai A., Doi T., Expression of HER-2 in gastric cancer: comparison between protein expression and gene amplification using a new commercial kit Journal of Clinical Oncology 2004 22 14S
24. Kameda T., Yasui W., Yoshida K., Tsujino T., Nakayama H., Ito M., Ito H., Tahara E., Expression of ERBB2 in human gastric carcinomas: relationship between P185(ERBB2) expression and the gene amplification Cancer Research 1990 50 24 8002 8009
25. Hollywood D. P., Hurst H. C., A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines EMBO Journal 1993 12 6 2369 2375 (Pubitemid 23194187)